ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 138 filers reported holding ARRAY BIOPHARMA INC in Q1 2015. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $6,565,000 | +99.9% | 141,711 | +5.2% | 0.03% | +116.7% |
| Q1 2019 | $3,284,000 | +69.7% | 134,700 | -0.8% | 0.01% | +50.0% |
| Q4 2018 | $1,935,000 | -5.9% | 135,789 | +0.4% | 0.01% | +14.3% |
| Q3 2018 | $2,056,000 | -7.8% | 135,269 | +1.8% | 0.01% | -12.5% |
| Q2 2018 | $2,229,000 | +7.3% | 132,831 | +4.4% | 0.01% | +14.3% |
| Q1 2018 | $2,077,000 | +21.0% | 127,263 | -5.1% | 0.01% | +16.7% |
| Q4 2017 | $1,717,000 | +20.7% | 134,107 | +15.9% | 0.01% | +20.0% |
| Q3 2017 | $1,423,000 | +58.8% | 115,706 | +8.1% | 0.01% | +66.7% |
| Q2 2017 | $896,000 | -1.1% | 107,055 | +5.7% | 0.00% | 0.0% |
| Q1 2017 | $906,000 | +24.1% | 101,325 | +22.0% | 0.00% | 0.0% |
| Q4 2016 | $730,000 | -99.9% | 83,069 | -0.3% | 0.00% | +50.0% |
| Q3 2016 | $562,160,000 | +89.9% | 83,283 | +0.2% | 0.00% | +100.0% |
| Q2 2016 | $296,035,000 | +17.9% | 83,156 | -1.9% | 0.00% | 0.0% |
| Q1 2016 | $251,000,000 | -29.1% | 84,795 | +1.2% | 0.00% | 0.0% |
| Q4 2015 | $354,000,000 | +92328.2% | 83,795 | -0.4% | 0.00% | -50.0% |
| Q3 2015 | $383,000 | -99.9% | 84,138 | +0.8% | 0.00% | 0.0% |
| Q2 2015 | $601,595,000 | +2.2% | 83,439 | +4.4% | 0.00% | 0.0% |
| Q1 2015 | $588,804,000 | +56.8% | 79,892 | +0.6% | 0.00% | 0.0% |
| Q4 2014 | $375,524,000 | +27.5% | 79,392 | -3.8% | 0.00% | +100.0% |
| Q3 2014 | $294,622,000 | -21.8% | 82,527 | -0.1% | 0.00% | -50.0% |
| Q2 2014 | $376,601,000 | -4.9% | 82,588 | -2.0% | 0.00% | 0.0% |
| Q1 2014 | $396,117,000 | -3.9% | 84,280 | +2.5% | 0.00% | 0.0% |
| Q4 2013 | $412,128,000 | -15.5% | 82,261 | +4.9% | 0.00% | -33.3% |
| Q3 2013 | $487,972,000 | +34.1% | 78,452 | -2.1% | 0.00% | +50.0% |
| Q2 2013 | $363,936,000 | – | 80,162 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|